공지
- [ 2024-04-30 ] 2023년도 기관생명윤리위원회 2차 인증 결과 공고
- [ 2024-04-18 ] 보건복지부 공무원(디지털소통팀장, 일반임기제 4급) 공개모집 안내
- [ 2024-04-12 ] 2024년 한국호스피스·완화의료학회 춘계연수강좌 개최 안내(4/20)
- [ 2024-04-09 ] [제62회 콜로키움] 태아 성별 고지 제한 의료법 규정 위헌 결정의...
- [ 2024-04-09 ] 2024년 제1차 사전연명의료의향서 등록기관 지정 신청 안내
관련 논문
*정책원 미소장 자료이며 관련 논문 소개 게시판입니다. 게시물 관련링크를 눌러 소속기관에서 열람가능한지 확인해주시기 바랍니다.
lib@nibp.kr
글 수 4,668
| 발행년 : | 2016 |
|---|---|
| 구분 : | 국내학술지 |
| 학술지명 : | 한국임상약학회지 |
| 관련링크 : | http://www.riss.kr/link?id=A101956813 |
상급종합병원과 희귀난치성질환 전문병원의 희귀의약품 사용현황
- 저자명
최경숙, 정영미, 김유정, 김윤희, 구현민, 이병구, 이은숙, 이정연
- 학술지명
한국임상약학회지
- 권호사항
Vol.26 No.2 [2016]
- 발행처
한국임상약학회
- 자료유형
학술저널
- 수록면
121-127(7쪽)
- 언어
Korean
- 발행년도
2016년
- 초록 (Abstract)
- Objective: Until now, there is minimal number of research for overall domestic status of orphan drug use in Korea. The purpose of this study is to identify the list of orphan drugs available in Korea and to understand the status of orphan drug usage in tertiary Hospitals and rare incurable disease Hospital. Methods: We made domestic orphan drug lists based on available orphan drugs in Korea. Based on this lists, we conducted e-mail survey from August, 2014 to September, 2014 to identify domestic status of orphan drug usage including the availability and management of orphan drugs. Results: There are three hundred and eighteen orphan drugs (184 ingredients) registered in Ministry of Food and Drug Safety. Among the three hundred and eighteen orphan drugs, Two hundred and twenty-eight drugs (102 ingredients) were selected. Information on each item was collected and documented with generic and brand names, manufacturers, wholesalers, indications, FDA approval status and insurance coverage. Forty-three tertiary hospitals and thirty-two rare incurable hospitals responded to the survey questionnaire (57.3%). According to the survey result, the antineoplastics and immunomodulating agents group has the highest percentage (40%) usage in the hospital. Of fortythree tertiary hospitals, thirteen hospitals manage orphan drugs separately (30.2%). Based on the reply, most of the healthcare professionals commented the drug information related to efficacy and safety including medication counseling of orphan drugs is insufficient. Conclusion: Through this study we anticipate providing an understanding of orphan drug usage status in Korea. We found the limited resources to the information on orphan drugs and this information requires updating on a regular basis. This can be the basis for further studies about preparing drug information, educational resources for rare disease patients.
- 목차 (Table of Contents)
- ABSTRACT
- 연구방법
- 국내 희귀의약품 등록 현황
- 국내 희귀의약품 사용실태 및 교육현황 설문조사
- 연구결과
- 국내 희귀의약품 등록 현황
- 국내 희귀의약품 사용현황 관련 설문조사
- 희귀의약품에 대한 인지도
- 희귀의약품 사용 및 관리현황
- 희귀의약품관련 정보의 필요성
- 희귀의약품 관련 의료진 및 환자교육현황
- 고찰
- 결론
- 감사의 말씀
- 참고문헌
- 별첨 1. 국내 희귀의약품 사용실태 및 교육현황 설문문항
(†04522) 서울 특별시 중구 남대문로 113 DB다동빌딩 5층
TEL : 02-737-8970 (기획운영팀)
Copyright (c)KONIBP All Right Reserved.
Copyright (c)KONIBP All Right Reserved.
2sisstore
